40 results
DEF 14A
PRLD
Prelude Therapeutics Inc
29 Apr 21
Definitive proxy
4:05pm
your stock ownership, you may contact our Investor Relations department at https://investors.preludetx.com/investor-relations or call Melissa Forst … , Inc., a securities firm. Ms. Dier previously served as a supervising senior accountant at the audit department of KPMG Peat Marwick, an accounting
8-K
EX-10.1
PRLD
Prelude Therapeutics Inc
10 Apr 24
Departure of Directors or Certain Officers
4:05pm
Wilmington, Delaware 19805 USA
Attn: Contracts Department
contracts@preludetx.com
Consultant: Laurent Chardonnet
737 Kennett Pike
Chadds Ford, PA 19317
PRE 14A
38cisfpuqm4 ntb
18 Apr 23
Preliminary proxy
4:00pm
8-K
EX-4.1
dhlsrfoxfa9
11 Dec 23
Prelude Therapeutics Announces $25 Million Private Placement
9:17am
8-K
EX-4.1
nx3w6c4k
19 May 23
Prelude Therapeutics Announces Launch of Proposed Public Offering
4:06pm
DRS
EX-4.3
7zgoidfg
21 Dec 20
Draft registration statement
12:00am
8-K
EX-1.1
7rb3nv
19 May 23
Prelude Therapeutics Announces Launch of Proposed Public Offering
4:06pm
DRS
ldv0bd
21 Dec 20
Draft registration statement
12:00am
424B4
jqu9nxck719u 1w4
7 Jan 21
Prospectus supplement with pricing info
4:11pm